The Type 2 Diabetes Market is estimated at US$47.3 billion in 2026 and is projected to grow at a CAGR of 8% to reach US$87.5 billion by 2034.
Its value chain includes drug manufacturers, device companies, pharmacies, clinics, payers, digital health platforms, and chronic care providers. Core applications include oral therapy, injectable treatment, glucose monitoring, weight linked disease management, hospital endocrinology care, and primary care based chronic disease support.
This product will be delivered within 1-3 business days.
Market Overview
The Type 2 Diabetes Market covers drug therapies, monitoring solutions, care pathways, and lifestyle support tools used to manage chronic metabolic dysfunction and glycemic control in type two diabetes.Its value chain includes drug manufacturers, device companies, pharmacies, clinics, payers, digital health platforms, and chronic care providers. Core applications include oral therapy, injectable treatment, glucose monitoring, weight linked disease management, hospital endocrinology care, and primary care based chronic disease support.
Key Companies Analysed
- Novo Nordisk
- Eli Lilly
- Sanofi
- Merck & Co
- AstraZeneca
- Boehringer Ingelheim
- Johnson & Johnson
- Abbott
- Roche
- Medtronic
- Dexcom
- Abbott Diabetes Care
- Teva Pharmaceutical Industries
- Sun Pharmaceutical
- Dr. Reddy’s Laboratories
- Viatris
- Pfizer
- Novartis
- Amgen
- Bristol Myers Squibb
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Type 2 Diabetes Market Overview
3. Type 2 Diabetes Market Dynamics
4. Type 2 Diabetes Market Strategic Analysis
5. Global Type 2 Diabetes Market Size, Share and Forecast, 2025-2034
6. North America Type 2 Diabetes Market Outlook to 2034
7. Europe Type 2 Diabetes Market Outlook to 2034
8. Asia-Pacific Type 2 Diabetes Market Outlook to 2034
9. Middle East and Africa Type 2 Diabetes Market Outlook to 2034
10. South and Central America Type 2 Diabetes Market Outlook to 2034
11. Type 2 Diabetes Market Competitive Landscape
12. Appendix
Companies Mentioned
- Novo Nordisk
- Eli Lilly
- Sanofi
- Merck & Co
- AstraZeneca
- Boehringer Ingelheim
- Johnson & Johnson
- Abbott
- Roche
- Medtronic
- Dexcom
- Abbott Diabetes Care
- Teva Pharmaceutical Industries
- Sun Pharmaceutical
- Dr. Reddy’s Laboratories
- Viatris
- Pfizer
- Novartis
- Amgen
- Bristol Myers Squibb
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 47.3 Billion |
| Forecasted Market Value ( USD | $ 87.5 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
